PMID: 2115191Jan 1, 1990Paper

The effect of dialyzer reuse on peak expiratory flow rate

Respiratory Medicine
A Davenport, A J Williams

Abstract

Peak expiratory flow rates were measured during routine haemodialysis in 18 patients with chronic renal failure who were in receipt of thrice weekly haemodialysis treatment, using both a new cuprophan dialyzer and then the same dialyzer after reprocessing. Acetate buffered dialysate was used on both occasions. The peak expiratory flow rates fell by 10 +/- 0.3%, mean +/- sem, during the first hour of treatment with the new dialyzer, and in seven patients (39%) the fall was greater than 15%. Whereas the reduction in peak expiratory flow rates was significantly less with reuse, 4 +/- 0.1% (P less than 0.5). Similarly, the fall in arterial oxygen tension was also reduced on reuse from 28 +/- 1.2% to 14 +/- 1.3% at 30 min (P less than 0.05) and from 30 +/- 1.4% to 18 +/- 3.1% (P less than 0.05) at 60 min of dialysis. There was also a reduction in the fall in the peripheral platelet count at 30 min of dialysis from 14 +/- 0.8% to 9 +/- 0.4% with reuse (P less than 0.05). However, there was no change in dialysis associated leukopenia with reuse of the dialyzer membrane. These results suggest that reprocessing the dialyzer membrane alters its biocompatibility characteristics resulting in an improvement in biocompatibility and further s...Continue Reading

References

Jan 1, 1979·Journal of Dialysis·T IkedaK Ei
Mar 1, 1975·Chest·M D BischelJ G Mohler
Jan 1, 1979·Nephron·S G MassryD A Goldstein
Oct 1, 1979·Archives of Internal Medicine·F Dumler, N W Levin
Jul 22, 1978·British Medical Journal·P AljamaD N Kerr
Apr 7, 1977·The New England Journal of Medicine·P R CraddockH S Jacob
Jul 1, 1987·Kidney International·R C VanholderS M Ringoir
Jan 1, 1985·American Journal of Nephrology·M S OhH J Carroll
Feb 1, 1985·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·R J Foley, W B Reeves
Nov 17, 1984·Lancet·J MorleyC P Page
Oct 4, 1984·The New England Journal of Medicine·R M HakimF K Port
Jan 1, 1984·International Archives of Allergy and Applied Immunology·C P PageJ Morley
May 1, 1983·Kidney International·W A De BackerM E De Broe
May 29, 1980·The New England Journal of Medicine·F C Dohan

❮ Previous
Next ❯

Citations

May 17, 2006·Wiener klinische Wochenschrift·Susanne M LangHelmut Schiffl
Mar 23, 2006·Seminars in Dialysis·Eduardo Lacson, J Michael Lazarus
May 13, 2006·Seminars in Dialysis·Zbylut J Twardowski
Sep 1, 1993·Kidney International·R M Hakim
Aug 11, 2020·Anesthesiology·Philip J PeytonAndre De Wolf

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.